Skip to content

MRK vs PFE: Dividend Comparison

MRK$143.37
Merck & Co., Inc.
Health Care
vs
PFE$28.46
Pfizer Inc
Health Care

Dividend data as of

Merck & Co., Inc. (MRK) and Pfizer Inc (PFE) are both in the Health Care sector, making them natural rivals for dividend investors. PFE offers a significantly higher 5.96% yield compared to MRK's 2.33%, a gap of 3.63%. For dividend growth, MRK leads with a 5-year CAGR of 6.0% versus PFE's 2.0%. Both stocks carry a "Safe" dividend safety rating. Both are classified as Dividend Contenders.

Verdict

Best for Income
PFE
Higher yield at 5.96%
Best for Growth
MRK
5yr CAGR of 6.0%
Best for Safety
Tie
Similar safety profiles

Track MRK and PFE in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$143.37
$28.46
Dividend Yield
2.33%
5.96%
Annual Dividend
$3.40
$1.72
5yr Div CAGR
6.0%
2.0%
3yr Div CAGR
5.2%
1.6%
Consecutive Years
15
16
Payout Ratio
3.43%
2.46%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$233/yr
$596/yr

Yield Analysis

MRK
2.33%
PFE
5.96%

PFE yields 3.63% more than MRK. In dollar terms, MRK pays $3.40/share vs PFE's $1.72/share annually.

Dividend Growth

MRK 5yr CAGR
6.0%
decelerating
PFE 5yr CAGR
2.0%
steady

MRK: Dividend growth is slowing — the 3-year CAGR of 5.2% trails the 5-year rate of 6.0% and the 10-year rate of 6.8%.

PFE: Dividend growth has been steady, with a 3-year CAGR of 1.6% and a 5-year CAGR of 2.0% (10-year: 4.2%).

Dividend Safety

MRK
Safe
Payout Ratio3%
PFE
Safe
Payout Ratio2%

MRK: The payout ratio of 3% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 0.3x.

PFE: The payout ratio of 2% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 0.4x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
MRK
PFE
$10,000
$233/yr
$596/yr
$50,000
$1,167/yr
$2,980/yr
$100,000
$2,333/yr
$5,960/yr

What does $10,000 buy in MRK vs PFE today?

At $143.37 per share, $10,000 buys about 69.7 shares of Merck & Co., Inc. (MRK). Each share pays $3.40 per year in dividends, so the position starts out generating roughly $237 per year — about $20 a month.

At $28.45 per share, $10,000 buys about 351.4 shares of Pfizer Inc (PFE). Each share pays $1.72 per year in dividends, so the position starts out generating roughly $604 per year — about $50 a month.

PFE is the larger income stream from day one: $367 per year more on the same $10,000 invested.

What could $10,000 of MRK or PFE income look like in 10 years?

Merck & Co., Inc. (MRK) has raised its dividend about 6.0% a year over the past five years. If that pace held, the $233 per year that $10,000 generates today at the current 2.33% yield would reach $418 per year by 2036 — a 4.2% yield on the original cost.

Pfizer Inc (PFE) has raised its dividend about 2.0% a year over the past five years. If that pace held, the $596 per year that $10,000 generates today at the current 5.96% yield would reach $724 per year by 2036 — a 7.2% yield on the original cost.

On those trailing rates, PFE pays more in 2036: $724 versus $418 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would MRK's dividend growth overtake PFE's higher yield?

Merck & Co., Inc. (MRK) yields less today (2.33% vs 5.96%) but has grown its dividend faster — 6.0% vs 2.0% a year over the past five years. If both trends continued, a $10,000 position in MRK would start out-earning the same position in PFE around 2051 (roughly 25 years from now), paying about $1,001 per year at the crossover. Before that point, PFE pays more each year; after it, the gap compounds in MRK's favor.

Can MRK and PFE afford their dividends?

Merck & Co., Inc. (MRK) earns $1.00 per share against $3.40 paid out in dividends — 0.3x coverage (a 3% payout ratio).

Pfizer Inc (PFE) earns $0.70 per share against $1.72 paid out in dividends — 0.4x coverage (a 2% payout ratio).

Coverage is similar for both, so neither dividend looks meaningfully more stretched than the other on current earnings.

Which fits an early-retirement income portfolio better, MRK or PFE?

For income you need right now, Pfizer Inc (PFE) leads: $100,000 invested today pays about $497 a month at the current 5.96% yield, versus $194 a month from Merck & Co., Inc. (MRK) at 2.33%.

With a decade or more before the income is needed, MRK's faster dividend growth (6.0% vs 2.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: MRK has raised its dividend 15 consecutive years; PFE has raised its dividend 16 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $526/yr in MRK vs $1,292/yr in PFE by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.